Analyst Robert Willoughby works at CREDIT SUISSE and is covering the the Healthcare sector with 132 price targets and ratings documented since 2014 spanning on 7 stocks. Previously, Robert Willoughby worked at BAML.
Robert Willoughby's average stock forecast success ratio is 51.24% with an average time for price targets to be met of 153.14 days.
Most recent stock forecast was given on CVS, CVS Health Corporation at 08-Aug-2022.
Analyst best performing recommendations are on DPLO.
The best stock recommendation documented was for MCK (MCKESSON CORPORATION) at 11/5/2020. The price target of $178 was fulfilled within 5 days with a profit of $10.01 (5.96%) receiving and performance score of 11.92.
Average potential price target upside
Currently, out of the existing stock ratings of Robert Willoughby - 3 which are a Buy (23.08%), 10 which are a Hold (76.92%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
390
$107.34 (37.97%)
375
1 months 14 days ago
37/45 (82.22%)
$48.64 (20.46%)
135
Sell
307
$24.34 (8.61%)
210
3 months 29 days ago
4/4 (100%)
$-1 (2.96%)
19
Hold
307
$24.34 (8.61%)
250
3 months 30 days ago
3/3 (100%)
$-8.41 (-4.50%)
27
Buy
360
$77.34 (27.36%)
255
3 months 30 days ago
15/25 (60%)
$114.67 (26.46%)
79
Buy
335
$52.34 (18.52%)
260
3 months 30 days ago
17/21 (80.95%)
$57.99 (20.82%)
99
